menu
    • menu

    Company profile for AI Proteins

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AI Proteins is revolutionizing protein design by combining artificial intelligence with cutting-edge science to create novel, functional proteins. Our mission is to harness the power of AI to design de novo proteins for applications in therapeutics, diagnostics, and industry, addressing critical global challenges. By blending deep learning and structural biology, we rapidly engineer proteins with unmatched precision and functi...
    AI Proteins is revolutionizing protein design by combining artificial intelligence with cutting-edge science to create novel, functional proteins. Our mission is to harness the power of AI to design de novo proteins for applications in therapeutics, diagnostics, and industry, addressing critical global challenges. By blending deep learning and structural biology, we rapidly engineer proteins with unmatched precision and functionality. Committed to innovation, sustainability, and collaboration, we strive to transform industries and improve lives. Join us in shaping the future of protein science and unlocking its vast potential.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AI ProteinsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20 Overland St. Boston MA 02215
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aiproteins.bio/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AI Proteins Secures $41.5M For De Novo Miniproteins Therapy
    AI Proteins Secures $41.5M For De Novo Miniproteins Therapy

    19 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251119922798/en/AI-Proteins-Raises-%2441.5M-Series-A-Financing-to-Advance-De-Novo-Miniproteins-as-a-New-Therapeutic-Modality

    BUSINESSWIRE
    19 Nov 2025
    Share Share
    AI Proteins Appoints James Bowman as First CTO
    AI Proteins Appoints James Bowman as First CTO

    26 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250826782481/en/AI-Proteins-Announces-James-Bowman-as-Companys-First-Chief-Technology-Officer

    BUSINESSWIRE
    26 Aug 2025
    Share Share
    AI Proteins to Showcase Miniprotein Therapeutics at PEGS Boston 2
    AI Proteins to Showcase Miniprotein Therapeutics at PEGS Boston 2

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506477411/en/AI-Proteins-to-Present-Key-Advances-in-Miniprotein-Therapeutics-Development-at-PEGS-Boston-2025

    BUSINESSWIRE
    06 May 2025
    Share Share
    AI Proteins CEO to Speak at TED Stage on Miniprotein Therapeutics
    AI Proteins CEO to Speak at TED Stage on Miniprotein Therapeutics

    08 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250408651131/en/AI-Proteins-CEO-Chris-Bahl-to-Speak-at-TED-Main-Stage-on-Next-Generation-Miniprotein-Therapeutics

    BUSINESSWIRE
    08 Apr 2025
    Share Share
    AI Proteins Appoints Philip Brandish As Chief Development Officer
    AI Proteins Appoints Philip Brandish As Chief Development Officer

    12 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250212546420/en

    BUSINESSWIRE
    12 Feb 2025
    Share Share
    AI Proteins Partners Missouri University For Radioligand Therapy
    AI Proteins Partners Missouri University For Radioligand Therapy

    08 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108626389/en

    BUSINESSWIRE
    08 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search